Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI)

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Balducci, Anthony ^a   Helfer, Brooke M ^a   Ahrens, Eric T ^a,b   Ohanlon, Charles F ^a   Wesa, Amy K ^a  

^a Celsense Inc   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Arthritis; Biofunctional imaging; Contrast agent; Inflammation; Macrophages; Magnetic resonance imaging (MRI); Monocytes; Perfluorocarbon

Indexed keywords

CONTRAST MEDIUM; FLUORINE; FLUOROCARBON; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FLUORINE NUCLEAR MAGNETIC RESONANCE; IMAGE ANALYSIS; INFLAMMATORY CELL; LIMIT OF QUANTITATION; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALIA; RATTUS;

EID: 84862505408     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-24     Document Type: Article

References (47)

1. Silman AJ, Hochberg MC, Epidemiology of the rheumatic diseases Oxford University Press, Oxford; New York 2 2001
2. Firestein GS, Panayi GS, Wollheim FA, Rheumatoid arthritis Oxford University Press, Oxford; New York 2 2006
3. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Wunder A, Straub RH, Gay S, Funk J, Muller-Ladner U, Rheumatology (Oxford) 2005 44 1341 1349 10.1093/rheumatology/keh709 (Pubitemid 41637634)
4. Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Sugimoto H, Takeda A, Hyodoh K, Radiology 2000 216 569 575 10924587 (Pubitemid 30599883)
5. Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis. Woodburn J, Hennessy K, Steultjens MPM, McInnes IB, Turner DE, Journal of Foot and Ankle Research 2010 3 10 10.1186/1757-1146-3-10 20565792
6. Early rheumatoid arthritis-is there a window of opportunity? Cush JJ, The Journal of Rheumatology 2007 80 1 7 17985417 (Pubitemid 350076862)
7. Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'? Huizinga TWJ, Landewe RBM, Nat Clin Pract Rheum 2005 1 2 3 10.1038/ncprheum0015
8. Established rheumatoid arthritis-new imaging modalities. McQueen FM, Stergaard M, Best Practice & Research Clinical Rheumatology 2007 21 841 856 10.1016/j.berh.2007.05.001 23077452 (Pubitemid 47381242)
9. MRI evaluation of infectious and non-infectious synovitis: preliminary studies in a rabbit model. Strouse PJ, Londy F, DiPietro MA, Teo ELHJ, Chrisp CE, Doi K, Pediatr Radiol 1999 29 367 371 10.1007/s002470050609 10382217 (Pubitemid 29201766)
10. Molecular imaging: integration of molecular imaging into the musculoskeletal imaging practice. Biswal S, Resnick DL, Hoffman JM, Gambhir SS, Radiology 2007 244 651 671 10.1148/radiol.2443060295 17709823 (Pubitemid 47292078)
11. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Chan K-WA, Felson D, Yood R, Walker A, Arthritis Rheum 1994 37 814 820 10.1002/art.1780370606 8003053 (Pubitemid 24184530)
12. Moller Dohn U, Lassere M, Freeston J, Boyesen P, et al. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state. Gandjbakhch F, Conaghan PG, Ejbjerg B, Haavardsholm EA, Foltz V, Brown AK, J Rheumatol 2011 38 2039 2044 10.3899/jrheum.110421 21885514
13. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Kaiser MJ, Hustinx R, Foidart J, Malaise MG, Journal of nuclear medicine: official publication, Society of Nuclear Medicine 2004 45 956 964 (Pubitemid 47611682)
14. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F, Arthritis Rheum 2001 44 331 338 10.1002/1529-0131(200102)44:2<331::AID- ANR50>3.0.CO;2-0 11229463 (Pubitemid 32207026)
15. Kaiser WA. Hansch A, Frey O, Hilger I, Sauner D, Haas M, Schmidt D, Kurrat C, Gajda M, Malich A, Brauer R, Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol 2004 39 626 632
16. The impact of MRI on the clinical management of inflammatory arthritides. Weber U, Ostergaard M, Lambert R, Maksymowych W, Skeletal Radiol 2011 40 1153 1173 10.1007/s00256-011-1204-5 21847747
17. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. Beckmann N, Cannet C, Babin AL, Ble FX, Zurbruegg S, Kneuer R, Dousset V, Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009 1 272 298 10.1002/wnan.16 20049797
18. Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. König H, Sieper J, Wolf KJ, Radiology 1990 176 473 477 2367663 (Pubitemid 20225139)
19. Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis. Tamai K, Yamato M, Yamaguchi T, Ohno W, Arthritis Rheum 1994 37 1151 1157 10.1002/art.1780370807 8053952 (Pubitemid 24313314)
20. Rheumatoid Synovial Inflammation: Pixel-by-Pixel Dynamic Contrast-enhanced MR Imaging Time-Intensity Curve Shape Analysis - A Feasibility Study1. van der Leij C, van de Sande MGH, Lavini C, Tak PP, Maas M, Radiology 2009 253 234 240 10.1148/radiol.2531081722 19703863
21. Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging. Gaffney K, Cookson J, Blades S, Coumbe A, Blake D, Ann Rheum Dis 1998 57 152 157 10.1136/ard.57.3.152 9640130 (Pubitemid 28244254)
22. Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced magnetic resonance imaging. Ostergaard M, Stoltenberg M, Henriksen O, Lorenzen I, A study of the effect of intra-articular methylprednisolone on the rate of early synovial enhancement. Br J Rheumatol 1996 35 50 59
23. Imaging inflammation of the pancreatic islets in type 1 diabetes. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R, PNAS 2004 101 12634 12639 10.1073/pnas.0404307101 15304647 (Pubitemid 39122075)
24. Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritis. Beckmann N, Falk R, Zurbrugg S, Dawson J, Engelhardt P, Magn Reson Med 2003 49 1047 1055 10.1002/mrm.10480 12768583 (Pubitemid 36627284)
25. Detection of Synovial Macrophages in an Experimental Rabbit Model of Antigen-induced Arthritis: Ultrasmall Superparamagnetic Iron Oxide-enhanced MR Imaging. Lutz AM, Seemayer C, Corot C, Gay RE, Goepfert K, Michel BA, Marincek B, Gay S, Weishaupt D, Radiology 2004 233 149 157 10.1148/radiol.2331031402 15333767 (Pubitemid 39280969)
26. MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles. Dardzinski BJ, Schmithorst VJ, Holland SK, Boivin GP, Imagawa T, Watanabe S, Lewis JM, Hirsch R, Magn Reson Imaging 2001 19 1209 1216 10.1016/S0730-725X(01)00448-9 11755731 (Pubitemid 34016586)
27. Ultrasmall Supraparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging of Antigen-Induced Arthritis: A Comparative Study Between SHU 555 C, Ferumoxtran-10, and Ferumoxytol. Simon GH, von Vopelius-Feldt J, Fu Y, Schlegel J, Pinotek G, Wendland MF, Chen M-H, Daldrup-Link HE, Invest Radiol 2006 41 45 51 10.1097/01.rli.0000191367.61306.83 16355039 (Pubitemid 44378278)
28. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Ahrens ET, Young WB, Xu H, Pusateri LK, Biotechniques 2011 50 229 234 21548906
29. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C, Magn Reson Med 2011 65 1144 1153 10.1002/mrm.22702 21305593
30. Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stage. Flogel U, Su S, Kreideweiss I, Ding Z, Galbarz L, Fu J, Jacoby C, Witzke O, Schrader J, Am J Transplant 2011 11 235 244 10.1111/j.1600-6143.2010. 03372.x 21214858
31. Kadayakkara DK, Ranganathan S, Young WB, Ahrens ET, Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI 2012
32. Visualization of Abscess Formation in a Murine Thigh Infection Model of Staphylococcus aureus by F-Magnetic Resonance Imaging (MRI). Hertlein T, Sturm V, Kircher S, Basse-Lusebrink T, Haddad D, Ohlsen K, Jakob P, PLoS One 2011 6 18246 10.1371/journal.pone.0018246 21455319
33. Early assessment of pulmonary inflammation by 19F MRI in vivo. Ebner B, Behm P, Jacoby C, Burghoff S, French BA, Schrader J, Flogel U, Circ Cardiovasc Imaging 2010 3 202 210 10.1161/CIRCIMAGING.109.902312 20061515
34. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Flogel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J, Circulation 2008 118 140 148 10.1161/CIRCULATIONAHA.107.737890 18574049
35. Autoimmunity to type II collagen an experimental model of arthritis. Trentham DE, Townes AS, Kang AH, J Exp Med 1977 146 857 868 10.1084/jem.146.3. 857 894190 (Pubitemid 8175993)
36. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Shou J, Bull CM, Li L, Qian HR, Wei T, Luo S, Perkins D, Solenberg PJ, Tan SL, Chen XY, et al. Arthritis Res Ther 2006 8 28 10.1186/ar1883 16507131
37. Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G: In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI. Weise G, Exp Neurol 2011 229 494 501 10.1016/j.expneurol.2011.03.020 21459088
38. The Rician distribution of noisy MRI data. Gudbjartsson H, Patz S, Magn Reson Med 1995 34 910 914 10.1002/mrm.1910340618 8598820
39. In Vivo Cytometry of Antigen-Specific T Cells Using F-19 MRI. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET, Magn Reson Med 2009 62 747 753 10.1002/mrm.22063 19585593
40. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET, Magn Reson Med 2007 58 725 734 10.1002/mrm.21352 17899609 (Pubitemid 47556877)
41. Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. Bolon B, Stolina M, King C, Middleton S, Gasser J, Zack D, Feige U, J Biomed Biotechnol 2011 2011 569068 21253435
42. A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Bardos T, Szabo Z, Czipri M, Vermes C, Tunyogi-Csapo M, Urban RM, Mikecz K, Glant TT, Ann Rheum Dis 2005 64 981 987 10.1136/ard.2004.029710 15640265 (Pubitemid 40909510)
43. Magnetic resonance imaging in spondyloarthritis. Marzo-Ortega H, McGonagle D, Bennett AN, Curr Opin Rheumatol 2010 22 381 387 10.1097/BOR.0b013e328339381e 20386452
44. Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints. Barton NJ, Stevens DA, Hughes JP, Rossi AG, Chessell IP, Reeve AJ, McQueen DS, J Inflamm (Lond) 2007 4 13 10.1186/1476-9255-4-13 (Pubitemid 47062938)
45. Fluorous micro- and nanophases with a biomedical perspective. Riess JG, Tetrahedron 2002 58 4113 4131 10.1016/S0040-4020(02)00262-4 (Pubitemid 34467039)
46. Perfluorocarbons: Life sciences and biomedical uses dedicated to the memory of Professor Guy Ourisson, a true RENAISSANCE man. Krafft MP, Riess JG, Journal of Polymer Science, Part A: Polymer Chemistry 2007 45 1185 1198 10.1002/pola.21937 (Pubitemid 46543057)
47. Oxygen therapeutics: perfluorocarbons and blood substitute safety. Cohn CS, Cushing MM, Crit Care Clin 2009 25 399 414 10.1016/j.ccc.2008.12.007 19341916